ICH Stability Requirements and Challenges

This training program will detail the requirements for ICH stability studies, discuss how to design stability programs for your drug product, and list analytical methods requirements. It will also focus on how to interpret the data generated by the stability programs.

Purchase using Webinar All-Access Pass
One User Unlimited access to all recorded webinars for 6 Months

Recorded Version Only

(PPT + Recorded Streaming Link)

1x Person - Unlimited viewing for 6 Months (For multiple locations contact Customer Care)
rec Recorded Link and Ref. material will be available in My Account Section
Last Recorded Date: Sep-2018

Download File Only

(PPT + Recorded Training File)

Downloadable file is for usage in one location only.
(For multiple locations contact Customer Care)
Downloadable link along with the materials will be emailed within 2 business days
Customer Care

Fax: +1-650-362-2367

Email: customercare@fdatrainingalert.com

Follow us:
Why Should You Attend:

Performing stability studies is often considered a routine task in the development cycle. However, if they are not designed and executed properly the results can be disastrous. Ineffective stability programs can lead to an assignment of shortened shelf life and/or delays in regulatory approvals. Given the options outlined in the ICH stability guidance, it is important to understand which options apply and how to implement them for your product.

This presentation will cover the ICH stability requirements, how to design the programs taking into account the drug product specifics and common challenges which can occur during these programs.

Learning Objectives:
  • Understanding what are the requirements for ICH stability studies
  • Learning the how to design stability programs for your drug product
  • Understanding the analytical methods requirements
  • How to interpret the data generated by the stability programs
Areas Covered in the Webinar:
  • Background and Overview of ICH Q1
    • What are the requirements for stability programs
    • What are the analytical method requirements, what needs to be measured
    • Stability indicating methods – what are they?
  • Designing Stability Studies
    • Standard programs vs matrixing vs. bracketing
    • ANDA stability requirements
  • Data Analysis
    • Tracking and trending
    • OOS vs OOT
    • Setting specifications and shelf life
Who Will Benefit:
  • Drug Development Professionals
  • CMC Analytical
  • Stability Managers
  • Manufacturing
  • Quality Assurance
  • Regulatory Affairs
  • Program Management
Instructor Profile:
Wayland Rushing Wayland Rushing

Sr Scientific Advisor, ABC Laboratories

Dr. Wayland Rushing is a technical expert in chemistry, manufacturing and controls (CMC) program design, analytical development and regulatory submissions. Over his 15-year career, he has led CMC development programs for a wide array of biopharmaceuticals, including parenterals, inhalation drugs, and other pharmaceuticals with complex delivery systems.

Dr. Rushing is a subject matter expert in HPLC and GC method development and validation, extractables and leachables program design and regulatory submission requirements; has drafted multiple IND and NDA submissions; and assists ABC clients in responding to FDA deficiency letters. He currently serves on Parenteral Drug Association (PDA) advisory committees for Technology Transfer and Elastomeric Closures and Seals Presentation Summary and was co-author of PDA TR 65, Technology Transfer.

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@fdatrainingalert.com call +1-888-771-6965 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

You Recently Viewed